top of page

Our mission at Neurodiction

Neurodiction aims to collect and distribute a variety of digital health tools to public to help physicians, researchers, and patients to diagnose, treat, and manage neurological disorders. Most neurologic disorders become chronic conditions and patients suffer from them for extended periods of time. Each individual patient is different from others, therefore medical decisions, practices, interventions and/or products should be tailored to the individual patient based on their predicted response or risk of disease (personalized medicine).

We aim to use the power of Artificial Intelligence, Machine learning, and advanced statistical modeling to tailor diagnostic and therapeutic decisions according to the needs of each patient. The priority of our team at Neurodiction is to help with treatment and management of patients with a variety of neurologic disease including migraine, chronic pain, stroke, Parkinson's disease, Alzheimer's disease and other dementia. As our knowledge in medicine expand by the day, it is becoming harder to keep up with the breadth of the new information. Physicians and researchers can use the help of Artificial Intelligence to help with their decision making. Our team at Neurodiction develop Digital Health Tools to support physicians and researchers with their decisions.

The material that we present on this website, will not be limited to the tools that we create. In our blog posts, we will talk about management of all neurological disorders as well as the larger medical field. We will talk about our work, other new and upcoming tools by other groups, and how our Artificial Intelligence powered models can improve disease management. There are many other useful information around the web for patients with Neurological conditions. We will discuss some of these resources in our posts and will help our audience to find trusted medical resources.

4 views0 comments

Recent Posts

See All

Title: "Assessing Risk of Incident Cognitive Impairment Using Stages of Objective Memory Impairment (SOMI) and CSF biomarkers" Authors: Kellen K. Petersen PhD, Ellen Grober PhD, Richard B. Lipton MD,

Title: Comparison of Plasma-based Biomarkers and Cognitive Assessments in predicting progression of MCI to Dementia Authors: Bhargav T. Nallapu, PhD, Kellen K. Petersen, PhD, Richard B. Lipton, MD, Da

Title: Stages of Objective Memory Impairment (SOMI) Predicts Incident Cognitive Impairment: Results from the Knight ADRC Authors: Ellen Grober PhD, Kellen K. Petersen PhD, Ali Ezzati MD, Jason Hassen

Post: Blog2_Post
bottom of page